Omalizumab Disease Interactions
There is 1 disease interaction with omalizumab.
Omalizumab (applies to omalizumab) malignancies
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Skin Cancer, History - Skin Cancer
In clinical trials malignancies have been observed in patients receiving omalizumab. Periodic examination is recommended for all patients, particularly those with risk factors for cancer. Caution should be exercised when considering omalizumab for the treatment of patients with a history of malignancies, those who have a known malignancy, or when continuing treatment in patients who develop malignancy while receiving this agent.
References
- "Product Information. Xolair (omalizumab)." Genentech (2003):
Omalizumab drug interactions
There are 9 drug interactions with omalizumab.
More about omalizumab
omalizumab consumer information
Check interactions
Reviews (228)
Side effects
Dosage information
During pregnancy
Drug class: selective immunosuppressants
Breastfeeding
Patient resources
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.